Guidelines
From the Journals
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...
Guidelines
NAMS affirms value of hormone therapy for menopausal women
Recent research supports individualized care to maximize benefits and minimize risks.
Guidelines
New update focuses on NAFLD in lean people
Lean individuals older than 40 with type 2 diabetes should be screened for NAFLD, urge experts.
From the Journals
New European guidelines ‘drastically’ reduce statin eligibility
“The risk threshold in this new guideline means that almost nobody qualifies for treatment in many countries.”
Guidelines
New AHA checklist: Only one in five adults has optimal heart health
The U.S. population is well below optimal levels of cardiovascular health, according to the first study of the AHA’s new Life’s Essential 8 CV...
Guidelines
ACC/AHA issue clinical lexicon for complications of COVID-19
The document standardizes definitions for cardiovascular and noncardiovascular complications and sets out a framework to capture and better...
Guidelines
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
Experts elevate new drugs for diabetic kidney disease
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow...
Guidelines
New National Lipid Association statement on statin intolerance
The statement offers strategies to help patients stay on statin medications and suggests alternatives that can be used in patients who really...
Guidelines
New guideline for in-hospital care of diabetes says use CGMs
Patients with diabetes or newly recognized hyperglycemia get admitted to every patient service in the hospital, and their glycemic management can...
Guidelines
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR
ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2...